✦ LIBER ✦

Isofagomine, a Potent, New Glycosidase Inhibitor

✍ Scribed by Tina M. Jespersen; Wenling Dong; Dr. Michael R. Sierks; Dr. Troels Skrydstrup; Dr. Inge Lundt; Dr. Mikael Bols

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 260 KB
Volume: 33
Category: Article
ISSN: 0044-8249
DOI: 10.1002/anie.199417781

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Silanediols: A New Class of Potent Prote

Silanediols: A New Class of Potent Protease Inhibitors

✍ Scott McN. Sieburth; Thomas Nittoli; Alfred M. Mutahi; Luxuan Guo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

Sugar-Derived Di- and Tetrahydropyridazi

Sugar-Derived Di- and Tetrahydropyridazinones: Synthesis of New Glycosidase Inhibitors

✍ Chepuri Venkata Ramana; Andrea Vasella 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 German ⚖ 220 KB

Total Synthesis of Carolacton, a Highly

Total Synthesis of Carolacton, a Highly Potent Biofilm Inhibitor

✍ Thomas Schmidt; Prof. Dr. Andreas Kirschning 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB 👁 1 views

(−)-FR182877 Is a Potent and Selective I

(−)-FR182877 Is a Potent and Selective Inhibitor of Carboxylesterase-1

✍ Gregory C. Adam; Christopher D. Vanderwal; Erik J. Sorensen; Benjamin F. Cravatt 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

(−)-FR182877 Is a Potent and Selective I

(−)-FR182877 Is a Potent and Selective Inhibitor of Carboxylesterase-1

✍ Gregory C. Adam; Christopher D. Vanderwal; Erik J. Sorensen; Benjamin F. Cravatt 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Natural products constitute a rich source of structurally diverse compounds that display exceptional biochemical and cellular activities. Although many natural products bind reversibly to their protein targets to alter protein-protein interactions and/or catalytic activity, others produce their bi

Combretastatin A-4 prodrug: A potent inh

Combretastatin A-4 prodrug: A potent inhibitor of malignant hemangioendothelioma cell proliferation

✍ A.S. Böhle; I. Leuschner; H. Kalthoff; D. Henne-Bruns 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 167 KB 👁 1 views

Anti-vascular treatment by targeting proliferating endothelial cells has become a promising option in anti-neoplastic therapy. Combretastatin A-4 prodrug (CA-4PD) has been identified as a selective inhibitor of endothelial cell proliferation, acting by the interruption of microtubule assembly. In th